GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Autolus Therapeutics PLC (NAS:AUTL) » Definitions » Accumulated other comprehensive income (loss)

Autolus Therapeutics (Autolus Therapeutics) Accumulated other comprehensive income (loss) : $-28.93 Mil (As of Mar. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Autolus Therapeutics Accumulated other comprehensive income (loss)?

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings. Autolus Therapeutics's Accumulated other comprehensive income (loss) for the quarter that ended in Mar. 2024 was $-28.93 Mil.

Autolus Therapeutics's quarterly Accumulated other comprehensive income (loss) increased from Sep. 2023 ($-33.79 Mil) to Dec. 2023 ($-28.99 Mil) and increased from Dec. 2023 ($-28.99 Mil) to Mar. 2024 ($-28.93 Mil).

Autolus Therapeutics's annual Accumulated other comprehensive income (loss) declined from Dec. 2021 ($-8.57 Mil) to Dec. 2022 ($-38.90 Mil) but then increased from Dec. 2022 ($-38.90 Mil) to Dec. 2023 ($-28.99 Mil).

Autolus Therapeutics Accumulated other comprehensive income (loss) Historical Data

The historical data trend for Autolus Therapeutics's Accumulated other comprehensive income (loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Autolus Therapeutics Accumulated other comprehensive income (loss) Chart

Autolus Therapeutics Annual Data
Trend Sep16 Sep17 Sep18 Dec19 Dec20 Dec21 Dec22 Dec23
Accumulated other comprehensive income (loss)
Get a 7-Day Free Trial -8.69 -5.86 -8.57 -38.90 -28.99

Autolus Therapeutics Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Accumulated other comprehensive income (loss) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -33.26 -27.96 -33.79 -28.99 -28.93

Autolus Therapeutics Accumulated other comprehensive income (loss) Calculation

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings.

Autolus Therapeutics Accumulated other comprehensive income (loss) Related Terms

Thank you for viewing the detailed overview of Autolus Therapeutics's Accumulated other comprehensive income (loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

Autolus Therapeutics (Autolus Therapeutics) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Autolus Therapeutics PLC (NAS:AUTL) » Definitions » Accumulated other comprehensive income (loss)
Comparable Companies
ZYME VERA ALPN ALLO TARS TBPH TYRA ELVN AVXL LYEL OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
6A3A:Germany
Address
191 Wood Lane, The MediaWorks, London, GBR, W12 7FP
Website
https://www.autolus.com
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.